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Abstract 
Role 2 Afloat provides a damage control resuscitation and surgery facility in support of maritime, 
littoral and aviation operations.  REBOA offers a rapid, effective solution to exsanguinating 
haemorrhage from pelvic and non-compressible torso haemorrhage. It should be considered when 
the patient presents in a peri-arrest state, if surgery is likely to be delayed, or where the single 
operating table is occupied by another case. This paper will outline the data in support of 
endovascular haemorrhage control, describe the technique, and explore how REBOA could be 
delivered using equipment currently available in the Royal Navy Role 2 Afloat equipment module.  
Also discussed are potential future directions in endovascular resuscitation. 
 
Key Messages: 
• REBOA is part of an evolving advanced endovascular resuscitation system. 
• REBOA has the potential to offer rapid and effective anatomical control of bleeding, allowing for 
physiological optimisation before and during damage control surgery.  
• In the military setting, and particularly where access to surgery is limited, REBOA could save 
lives from haemorrhage. 
 
 
  
  
REBOA at Role 2 Afloat:  Resuscitative endovascular balloon occlusion of the aorta as a bridge to 
damage control surgery in the military maritime setting. 
Introduction 
The Royal Navy Role 2 Afloat (R2A) capability exists to support maritime, littoral and aviation 
operations by providing damage control resuscitation, including surgery, within 2 hours from the 
point of wounding according to NATO timelines.  The service may be deployed in support of 
conventional or special forces operations, or as part of a humanitarian and disaster relief response 
(Figure 1).  The system can be rapidly and flexibly delivered from a variety of maritime platforms, 
some of which have dedicated space pre-allocated, with equipment pre-embarked ready for 
immediate use. 
The majority of deployments utilise a 2-1-2 configuration, comprising of 2 emergency department 
resuscitation bays, 1 operating theatre table, and 2 level 3 critical care beds.  Manning comprises 
one consultant each from emergency medicine, general surgery and orthopaedics, plus 2 
consultants in anaesthesia.  The team may be augmented by a consultant physician where a 
particular requirement is anticipated.  The R2A is also equipped with extensive blood products, and 
basic laboratory facilities to support initial assessment, resuscitation and ongoing ICU care. 
Bleeding is the primary cause of death on kinetic combat operations 
The primary aim is to provide a high-readiness emergency surgical facility offering rapid 
haemorrhage control as part of a strategy of early, effective damage control resuscitation (1) (2).  A 
recent analysis of 4,500 military trauma deaths confirmed that the primary mode of death in combat 
is haemorrhage, accounting for over 90% of all deaths. The majority of deaths occur before even 
reaching a surgical facility (3).  A system combining advanced physician-led prehospital care, early 
blood product delivery and aggressive consultant-delivered acute hospital care has been shown to 
optimise survival from severe battlefield trauma, despite very complex injury patterns (4).  The 
ongoing development of systems with which to combat bleeding is a top priority in saving life.  
Non-compressible torso and pelvic haemorrhage is especially problematic and carries a high case 
fatality rate (5).  Conventional immediate interventions such as pressure dressings, combat 
tourniquets and haemostatic gauze are unlikely to gain control of bleeding from non-compressible 
sites. A patient presenting in extremis from this form of bleeding requires effective, immediate 
proximal haemorrhage control.  Whilst it is accepted that the injury patterns seen on recent military 
operations may differ from those found in future conflicts, bleeding is likely to remain the primary 
mode of death, as it is within civilian trauma cohorts (6).  Swift laparotomy or thoracotomy for aortic 
cross-clamping, alongside blood product resuscitation will be required.  If these are not available, or 
if there is a delay to gaining surgical control, death will ensue.   
In limited-capacity systems, such as the deployed R2A, an alternative endovascular solution which 
allows anatomical and physiological stabilisation would be of particular value, especially in situations 
where multiple casualties occur simultaneously, or where a single operating theatre is occupied by a 
prior case (7).  
Resuscitative endovascular balloon occlusion of the aorta 
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a novel form of haemorrhage 
control which has been proven to reduce bleeding and improve survival in animal models (8–11) 
Introduced by a femoral artery sheath, an endovascular balloon is inflated in the aorta, occluding the 
vessel and acting as an endovascular clamp (Figure 2). REBOA has been demonstrated to be 
  
efficacious in a large human case series (12). A prospective registry of 114 patients with critical 
haemodynamic instability in the United States (US) armed forces confirmed that in-hospital REBOA 
might be a viable alternative to immediate resuscitative thoracotomy (RT) for achieving rapid 
proximal control.  The cohort had an overall mean Injury Severity Score (ISS) of 31.5, and around half 
suffered traumatic cardiac arrest during initial resuscitation.  The study failed to demonstrate any 
significant difference between REBOA and RT in terms of mortality (72% vs 84% respectively), but 
concludes that REBOA is a viable option in centres where the expertise is available (13).  A Japanese 
retrospective observational study comparing REBOA with RT further suggested that in-hospital 
REBOA is equally effective in terms of adjusted mortality (14).  In this series of 259 cases, REBOA was 
the proximal control strategy in 74%, reflecting important international variations in haemorrhage 
control strategy.   A prospective randomised controlled trial of REBOA is about to commence in the 
UK, aiming to recruit 120 cases across 4 major trauma centres, in order to provide an analysis of 
efficacy and cost-effectiveness of the technique. For use within a R2A environment, REBOA is 
positioned as an additional therapy, to be used where profound instability exists, or where 
immediate surgical intervention is not possible due to logistical constraints. 
Three distinct anatomical aortic landing zones are described; Zone 1 – between left subclavian and 
coeliac artery, Zone 2 – between coeliac artery and the most caudal renal artery, Zone 3 – between 
the most caudal renal artery and the aortic bifurcation.  In clinical practice, Zones 1 and 3 are used as 
landing zones for REBOA.  Balloon positioning is ideally performed under direct fluoroscopic 
guidance.  However this is not available in a deployed R2A. Indeed, fluoroscopy is frequently not 
available within conventional emergency departments. Instead, anatomically-derived measurements 
can be used to insert the balloon catheter to an appropriate depth (15, 16), and an anteroposterior 
X-ray will confirm correct placement. 
Once the balloon is in-situ, resuscitation including administration of blood products, and emergency 
anaesthesia can then be performed.  The usual response to REBOA is a brisk, significant rise in 
systolic blood pressure.  REBOA is a temporary anatomical and physiological stabilisation tool, for 
critically unstable patients with haemorrhagic shock.  Its use is suggested where an operating 
theatre is not immediately available, or where cardiac arrest is imminent.  Although currently 
deployed high-volume infusion devices can often keep pace with severe haemorrhage in the 
preoperative and anaesthesia phases, there is no evidence that this is a superior strategy to gaining 
rapid endovascular control. Rapid haemorrhage control might reduce preoperative blood 
requirements, saving blood products for administration in-theatre or postoperatively once damage 
control surgery is complete.  As well as reducing the multiple adverse effects associated with 
massive transfusion, in a logistically challenged operation setting this might also conserve valuable 
blood stocks.  Currently available equipment for performing REBOA is listed in Table 1 and shown in 
Figure 3. 
 
14g Arterial Catheter (Leadercath, Vygon™) – for initial access as a mini-puncture device, prior to 
exchange for the large-bore sheath.  Contains a 16g, 7cm introducer needle, 460mm J-tipped 
guidewire and 6F, 18cm arterial catheter. 
Two-Lumen Central Venous Access Set (MAC, Arrow International™) – a two-lumen central access 
“trauma line” device with a 0.035” 45cm guidewire, dilator and a 10cm sheath with a 9F distal lumen, 
suitable for passage of the REBOA balloon.  
Embolectomy catheter (Syntel, Applied Medical™) – an endovascular balloon, originally designed for 
thrombus retrieval.  The 7F catheter is 80cm long, with the balloon capable of expanding to 15mm 
once inflated with 2.5ml of fluid.  
  
Table 1: The following REBOA items exist within the current equipment module for R2A. 
 
Suggested process 
The technique can easily be adapted for different clinical environments, or differing skillsets, and can 
be adjusted to suit the available equipment. This outline specifically refers to equipment carried 
within the maritime R2A, but could apply to any deployed military unit holding the same equipment 
(Box 1). 
Preparation and arterial cannulation 
The REBOA operator should brief the team and prepare the equipment.  The primary stage is 
identification of an arterial access site.  The right common femoral artery is the most common, and 
easiest for the right handed operator.  The femoral pulse should be sought, using conventional 
anatomical landmarks.  Once identified ultrasound should be used to confirm the anatomy.  
Following skin preparation and draping, local anaesthesia infiltration can be performed if required, 
aiming for vessel entry 2cm below the inguinal ligament.  A generous stab incision should be made 
at the insertion site, to facilitate passage of the devices through the skin, avoiding damage to their 
leading edges.  Using the 18g introducer needle from the MAC™ line set, advancing at 45̊ to the skin, 
the femoral artery should be punctured, using an open-needle technique (i.e. no needle attached).  
Brisk pulsatile flow of arterial blood should usually be observed.  Fix the needle firmly in place. Insert 
the J-tipped 45cm 0.035” MAC™ guidewire to at least half its length.  The wire should pass easily.  
Resistance, or a gritty sensation indicates that the wire is in a dissection flap, or possibly kinked – 
carefully remove the wire, confirm arterial flow from the needle, reposition if necessary. Once the 
wire is in-situ, remove the needle over the wire, leaving the wire in the vessel. At this point, take the 
Leadercath™ sheath and insert this fully into the artery, over the wire.  Ultrasound at this point may 
be used to confirm that the sheath and wire are still sited in the vessel.  Remove the wire and 
confirm that free- aspiration of blood is possible.  This step has been included to increase operator 
confidence that the lumen has been achieved, prior to committing to dilation for the larger MAC™ 
line - an experienced endovascular operator may choose to omit this.  Next, remove the Leadercath 
taking care to leave the guidewire in place.  Advance the MAC line over the wire, ideally with an 
assistant fixing the back end wire to avoid kinking.  Insert the MAC line fully, remove the dilator and 
guidewire together. Aspirate, flush and clamp the side ports. In the case of difficulty gaining access, 
a limited cut-down though a vertical incision over the access site can assist.  Blunt digital dissection 
is all that is required to identify the femoral artery, which can then be cannulated under direct 
vision.  The contralateral groin offers an alternative route.   
Insertion of balloon 
Remove the Syntel balloon catheter from its housing.  Attach a 5ml syringe filled with 0.9% saline or 
a 50:50 mix of saline and iodinated contrast (to enhance visibility on subsequent X-ray).  Aspirate air 
from the balloon. Do not test the balloon as this will make it bulky and prone to damage.  Use 
external landmarks to estimate catheter length to the desired landing zone.  For Zone 1 estimate 
catheter length from the femoral insertion site to midway between suprasternal notch and xiphoid 
process. A Zone 3 deployment is estimated from the femoral access site to the umbilicus (15, 16).  In 
a critically unstable patient with torso trauma, initial deployment in Zone 1 is advised. Zone 3 should 
be considered as an initial REBOA strategy where pelvic trauma is believed to be the primary source 
of bleeding.  Pass the balloon carefully through the MAC line valve, using the 10cm incremental 
markers to guide depth of insertion.  The balloon should pass freely, without resistance.  If 
  
resistance if felt, withdraw the balloon to the sheath and gently attempt again. Once at the desired 
depth, open the 3-way tap and deliver 2.5ml of fluid from the syringe, stopping if resistance is felt 
(Figures 4 and 5).  Turn the 3-way tap to isolate the balloon from the delivery syringe. Manually hold 
the balloon in place, as any cardiac output will tend to displace the balloon caudally. The sheath 
should be sutured firmly in place.   
Subsequent management 
A proximal systolic pressure increase of ~50mmHg is usual.  Volume expansion can be optimised if 
required, whilst preparations for surgery are made. Time is now key – REBOA offers a temporary 
solution and a bridge to damage control surgery.   Prolonged REBOA has been shown to increase 
circulating levels of lactate, interleukin-6, and an increase in vasopressor requirements (9). Partial 
REBOA (pREBOA), allowing a limited amount of forward flow, is more physiologically and 
haemodynamically tolerable option and might further extend the “golden hour” after traumatic 
injury (17, 18).  Pragmatically, an initial complete REBOA inflation, to achieve fast control is 
advocated.  If stability is achieved, and the up-stream pressures are supranormal, controlled partial 
deflation and pREBOA is reasonable, and associated with better outcomes (19).  Although this 
appears complex in a text description, it is highly intuitive and easily learned in a workshop setting.  
A radial arterial pressure line would be of value; if the pressure is supranormal, cautious balloon 
deflation by removing 0.5ml aliquots of fluid could be considered – obviously at the expense of some 
downstream bleeding. An X-ray should be acquired if transfer to theatre is not immediate, to 
confirm balloon positon.  The level of L2 usually indicates the level of the renal arteries – a Zone 1 
balloon should thus be positioned above this.  The level of L4 usually represents the aortic 
bifurcation, hence a Zone 3 inflation should be positioned between L4 and L2.   
Removal 
The REBOA sheath and balloon should be monitored closely once deployed, taking care to avoid 
accidental dislodgement.  A team member should be tasked with maintaining balloon position, as 
caudal migration will become likely as cardiac output increases following resuscitative measures.   
Once in the operating theatre, close liaison between anaesthetist and surgeon should take place 
regarding the timing of balloon deflation and removal.  This would usually be considered during or 
after initial damage control surgery, and a cautious, step-wise balloon deflation, (e.g. 0.5ml at a 
time) is proposed.  If haemodynamics remain favourable, and haemostasis is achieved, balloon 
removal can occur.  Prolonged presence of an undeployed balloon catheter and/or arterial sheath 
should be avoided – thrombus can easily form and compromise limb viability.   Fully deflate the 
balloon.  Gently remove the balloon catheter through the MAC line.  Three options now exist; 
remove the line and perform direct manual pressure over the access site for 10 minutes, remove the 
line with proximal vascular control and perform an arteriorrhaphy, or use a fascial suture to close 
the vessel.  As the device is 9F, the direct pressure option is possible, though in the setting of a 
potentially coagulopathic polytrauma patient there is a risk of further bleeding.  Also, the ability to 
test for coagulopathy might be suboptimal in the deployed maritime setting.  Formal arterial repair 
be time consuming, and might be outwith the usual practice of some surgeons.  The fascial suture 
technique, closing the cribriform fascia with a horizontal mattress suture applying compression over 
the point of insertion whilst the vessel is controlled with sloops is easy, fast and associated with a 
very low long term complication rate (20) (20).   
Other potential settings and developments 
  
REBOA could easily be applied in other military settings where access to an operating table might be 
compromised.  This could include use by the Commando Forward Surgical Group in support of 
littoral operations by the Royal Marines, or by British Army Role 2 Light Manoeuvre units.  
Prehospital REBOA has been reported (21), delivered by physicians of Londons Air Ambulance.  The 
procedure could easily be adopted for use by military Medical Emergency Response Teams 
physicians, and early prehospital use is likely to deliver the most overall clinical benefit.  A device, 
intended specifically for fluoroscopy-free deployment, is now approved for use in Europe (ER-REBOA 
catheter, Prytime Medical™), which might provide a more deliverable option for deployed use.   
REBOA offers a bridge to damage control surgery (22).  If initial stabilisation fails or cardiac arrest 
ensues, presence of an aortic catheter extends the options to include therapies such as selective 
aortic arch perfusion (SAAP) with blood or novel resuscitation fluids (23) (23).  If initial efforts still 
fail, rapid cooling with ice-cold saline boluses, and conversion to full cardiopulmonary bypass is 
possible.  This combination of techniques – emergency preservation and resuscitation (EPR) for 
cardiac arrest from trauma -  is currently under investigation (24).  It is likely that REBOA, SAAP and 
EPR will merge to form a hybrid advanced endovascular toolkit for severe haemorrhagic shock (25).  
A sound military REBOA programme is the first step towards exploiting these techniques to save 
lives in future. 
 
Formal training courses 
The Endovascular Hybrid Trauma and Bleeding Management (EVTM) workshop runs twice annually 
in Orebro, Sweden.  The course offers theoretical training, simulator sessions and live tissue work 
using an animal model of severe trauma.  It allows candidates to gain real-time, hands-on experience 
of performing REBOA, as well as a variety of other endovascular techniques such as stent-grafting, 
coiling and use of haemostatic glue, under the supervision of an expert multispecialty international 
faculty.  The Basic Endovascular Skills for Trauma (BEST) course, operated by the American College of 
Surgeons Committee offers an alternative, designed as a means to offering basic endovascular 
techniques to surgeons who have limited or no formal endovascular training.   
 
 
Conclusions 
REBOA offers a rapid, effective endovascular solution to exsanguination from pelvic or torso 
haemorrhage.  It should be considered where the patient presents in a peri-arrest state, or if there is 
likely to be a delay in providing rapid proximal haemorrhage control.  In particular, in a Role 2 Afloat 
configured as a 2-1-2 facility, REBOA offers a means of temporising a second shocked patient, should 
the operating table be in current use and therefore unavailable.  
  
 
Box 1 – REBOA procedural guideline: 
The following is a proposed as a guideline for performing REBOA in R2A 
1. Confirm indication – exsanguinating torso/pelvic haemorrhage and critical or peri-arrest state.  
Theatre unavailable or loss of cardiac output during anaesthesia likely. 
2. Open and prepare equipment, explain procedure to patient and team members. 
3. Identify femoral artery pulsation, using ultrasound to confirm. 
4. Infiltrate 10ml 1% lidocaine in skin and soft tissues around intended puncture site, 2cm below 
inguinal ligament. 
5. Make a generous stab-incision in the skin to allow passage of the sheath. 
6. Insert 18g introducer needle from MAC™ line set into femoral artery, fix needle in vessel with 
fingers, advance 0.035” guidewire, remove needle and insert Leadercath™ catheter over-the-
wire.  Confirm presence in artery using ultrasound.  Remove guidewire to confirm arterial blood 
flow; NB – this may not appear very pulsatile in the setting of profound hypotension. 
7. Re-insert 45cm guidewire from MAC™ line through Leadercath™ device, remove Leadercath™ 
ensuring the guidewire remains in the vessel.  Insert MAC line over guidewire using forward 
twisting motion.  If necessary, extend skin incision over guidewire.   Remove MAC line dilator 
and guidewire. Flush and lock side-ports. 
8. Insert 7F Syntel™ balloon through hydrostatic valve of MAC line. Insert to desired depth: 
 
a. For Zone 1 REBOA – estimate length from CFA insertion site to midway between xiphoid 
process and suprasternal notch (~45cm). 
 
b. For Zone 3 REBOA – estimate length from CFA insertion site to umbilicus (~30cm). 
 
9. Gently inflate Syntel™ balloon with 2.5ml 0.9% saline via 3-way tap, or until resistance is felt. 
10. Lock the balloon using the 3-way tap. 
11. Note time, and length of catheter at haemostatic valve of MAC™ line. 
Post-REBOA actions: 
 Secure sheath with sutures. 
Allocate team member to hold balloon shaft and avoid accidental catheter/sheath dislodgement 
or balloon deflation. 
Commence blood product transfusion and prepare for surgery. 
 Insert arterial pressure monitoring line in right radial artery. 
 If arterial pressure supra-normal, release 0.5ml aliquots from Syntel balloon. 
 If surgery will take >10 mins, obtain plain anteroposterior X-ray to confirm placement. 
 Deflation – coordinate between surgeon and anaesthetist, aim <30 mins esp Zone 1. 
 
Troubleshooting 
Balloon misplacement – isolated absent left arm pulse – too high. Presence of contralateral 
femoral pulse – balloon too low.  Deflate balloon, gently readjust position, reinflate and 
reassess, repeat X-ray if needed. 
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